6 unknown. 6 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 4 | Unknown 4 |
Follow Acute Lymphoblastic Leukemia: new trials by email Literature Review of Acute Lymphoblastic Leukemia trials Research Report on Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL Cladribine, Fludarabine - Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 32 | 2022-01-01 | 2022-10-13 |
| Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test - Acute Myeloid Leukemia in Remission, Lymphoma in Remission | Phase 2 / Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 227 | 2019-09-16 | 2021-09-28 |
| HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation Haplo donor stem cell transplantation, HLA 10/10 MUD stem cell transplantation - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 344 | 2018-08-01 | 2018-08-31 |
| CART-19 Cells For MRD Positive CD19+ ALL CART-19 - Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Unknown | Fujian Medical University | 20 | 2016-11-01 | 2017-01-23 |
| Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction Pentoxifylline Plus Chemotherapy, Placebo Plus Chemotherapy - Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Unknown | Ramón Óscar González-Ramella, Ph.D | 44 | 2015-01-01 | 2018-05-09 |
| Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: VDCLD regimen - Acute Lymphoblastic Leukemia | Phase 3 | Unknown | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. | 200 | 2013-12-01 | 2014-07-08 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (6) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Leukemia (6) · Leukemia, Lymphoid (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Bone Marrow Diseases (1) · Leukemia, Myeloid (1)
CTL019 chimeric antigen receptor (1) · Cladribine (1) · Cytarabine (1) · Drug Therapy (1) · Granulocyte Colony-Stimulating Factor (1) · Methotrexate (1) · Pentoxifylline (1) · fludarabine (1)
Assistance Publique - Hôpitaux de Paris (2) · Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. (1) · Fujian Medical University (1) · Ramón Óscar González-Ramella, Ph.D (1) · The First Affiliated Hospital of Soochow University (1)
China (3) · Belgium (1) · France (1) · Germany (1) · Mexico (1)
Jianda Hu, 86-13959169016 (1) · Olivier Hermine, MD (1) · Yue Han, MD/PhD (1) · Zhigang Yang (1)
PMID 11675328, PMID 16155013, PMID 17366834, PMID 18358930, PMID 21220611, PMID 21846410, PMID 21943236, PMID 22037714, PMID 22074157, PMID 22086414, PMID 22265847, PMID 22323480, PMID 23140366, PMID 23244073, PMID 39421449